IGC Pharma IGC
NYSE IGC
$0.31 +0.03 (+11.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

IGC Pharma (IGC) Gross Profit (2010 - 2025)

IGC Pharma (IGC) posted quarterly Gross Profit of $99000.0 for Q3 2025, down 50.0% year-over-year from $198000.0 in Q3 2024, and down 35.71% quarter-over-quarter from $154000.0 in Q2 2025.

IGC Pharma (IGC) Gross Profit (2010 - 2025) Analysis & Trends

IGC Pharma (IGC) has reported Gross Profit for 16 consecutive years, with $99000.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Gross Profit fell 50.0% year-over-year to $99000.0; the TTM figure through Sep 2025 stood at $511000.0 (down 23.16% YoY), while the FY2026 annual figure was $55000.0, down 91.11% from the prior year.
  • Gross Profit declined to $99000.0 in Q3 2025 per IGC's latest filing, from $154000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $255000.0 in Q2 2023 and bottomed at $26000.0 in Q2 2021.
  • Historically, Gross Profit has averaged $119368.4 across 5 years, with a median of $133000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Gross Profit surged 446.15% — and 2025, when it plunged 50.0%.
  • IGC Pharma's Gross Profit stood at $62000.0 in 2021, then jumped by 64.52% to $102000.0 in 2022, then surged by 30.39% to $133000.0 in 2023, then slipped by 21.8% to $104000.0 in 2024, then dropped by 4.81% to $99000.0 in 2025.
  • Business Quant data shows IGC's Gross Profit at $99000.0 in Q3 2025, $154000.0 in Q2 2025, and $154000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 IGC Pharma 30.17 Mn 29.90 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 99,000.00
Sep 30, 2025 99,000.00
Jun 30, 2025 154,000.00
Jun 30, 2025 154,000.00
Mar 31, 2025 154,000.00
Mar 31, 2025 154,000.00
Dec 31, 2024 104,000.00
Dec 31, 2024 104,000.00
Sep 30, 2024 198,000.00
Sep 30, 2024 198,000.00
Jun 30, 2024 163,000.00
Jun 30, 2024 163,000.00
Mar 31, 2024 171,000.00
Mar 31, 2024 171,000.00
Dec 31, 2023 133,000.00
Dec 31, 2023 133,000.00
Sep 30, 2023 174,000.00
Sep 30, 2023 174,000.00
Jun 30, 2023 255,000.00
Jun 30, 2023 255,000.00